SEC Form 4 · accession 0001104659-15-070633
CytomX Therapeutics, Inc. · CTMX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Period of report
Oct 14, 2015
Accepted (ET)
Oct 14, 2015 · 3:36 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001501989
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Oct 14, 2015 | C | 749,055 | — | A | 749,055 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series D Convertible Preferred StockF1 | — | Oct 14, 2015 | C | 749,055 | D | — | — | Common Stock | 749,055 | 0 | D |
Explanation of responses
- F1The Series D Convertible Preferred Stock converted into common stock on a one-for-one basis and had no expiration date.